SCIENTIFIC PROGRAMME

Preceptorship course in metastaticcolorectal cancer managementAintree University Hospital NHS Foundation Trust22-24 July 2015 - Liverpool, UK

Endorsed

General information

VenueThis live educational preceptorship course takes place at:

Aintree University Hospital NHS Foundation TrustLongmoor Lane - Liverpool, UK

LanguageThe official language of this live educational preceptorship course isEnglish.

Scientific secretariatEXCEMED - Excellence in Medical EducationSalita di San Nicola da Tolentino, 1/b - 00187 Rome, Italy

Programme Managers: Alessia Addessi & Giovanna RossiT +39 06 420413 252 - F +39 06 420413 677E-mail: info@excemed.org

Medical Advisor: Cristina Raimondi

EXCEMED is a Swiss Foundation with headquarters in 14, Rue du Rhône, 1204 Geneva, Switzerland

Organising secretariatMeridiano Congress InternationalVia Sapri, 6 - 00185 Rome, ItalyCongress Coordinator: David H. SlangenT +39 06 88 595 250 - F +39 06 88595 234E-mail: david.slangen@meridiano.it

1

follow us onEXCEMED_Onco

http://twitter.com/EXCEMED_Onco

Preceptorship course in metastaticcolorectal cancer management

EXCEMED live educational:

Preceptorship course in metastatic colorectalcancer management 22-24 July 2015 - Liverpool, UK

AimBased on current evidence, a multidisciplinary approach is stronglyrecommended for improving the clinical outcome and survival rates ofmetastatic colorectal cancer patients. This live educationalpreceptorship course will give participants the opportunity to observehow a multidisciplinary approach is applied within a centre ofexcellence. This live educational preceptorship course will bepractice-oriented and will allow participants to fully integrate into thedaily activity of the centre. The preceptorship encompasses lectures,clinical case study discussions, question and answer sessions andparticipation in a multidisciplinary team meeting.

Learning objectivesAfter attending the live educational preceptorship course, participantswill be able to:

• Define criteria for the resectability of liver metastases fromcolorectal cancer

• Summarise current evidence on diagnosis and therapy formetastatic colorectal cancer patients

• Apply the multidisciplinary approach in the management ofmetastatic colorectal cancer patients

Target audienceColorectal surgeons, hepatobiliary surgeons, medical oncologistswith an interest in colorectal cancer.

2

AccreditationEXCEMED (www.excemed.org) is accredited by the EuropeanAccreditation Council for Continuing Medical Education (EACCME®)to provide the following CME activity for medical specialists. The EACCME® is an institution of the European Union of MedicalSpecialists (UEMS), www.uems.net.

The CME accreditation of this EXCEMED “Preceptorship course inmetastatic colorectal cancer management” held on 22-24 July inLiverpool, UK is designated for a maximum of 11 (eleven) hours ofEuropean CME credits (ECMEC). Each medical specialist shouldclaim only those credits that he/she actually spent in theeducational activity. EACCME® credits are recognised by theAmerican Medical Association (AMA) towards the Physician’sRecognition Award (PRA). To convert EACCME® credit to AMA PRAcategory 1 credit, please contact the AMA.

EXCEMED adheres to the principles of the Good CME Practice Group(gCMEp).

3

This programme is

Endorsed

5

Share your opinion with usWe are always looking for ways to bring our educational activities tothe next level and meet your needs as a healthcare practitioner.You will be asked to answer a post-event online survey after thisevent to find out if the experience met your educational expectations.Your views also help us tailor future initiatives.

Thank you for taking the time to participate.

Scientific organiserGraeme PostonDepartment of Hepatobiliary SurgeryNorth Western Hepatobiliary CentreAintree University Hospitals Foundation TrustLiverpool, UK

Faculty membersAintree University Hospitals Foundation Trust - Liverpool, UK

Clare ByrneJeff GouldingHassan Malik

Graeme PostonChan TonHulya Wieshmann

Scientificprogramme

7

Wednesday, 22 July 2015

Meeting point: Entrance to the Elective Care Center (ECC)

12.30 Opening light lunch

13.20 Welcome and introductionG. Poston (Liverpool, UK)

13.30 NICE Colorectal cancer guidanceG. Poston (Liverpool, UK)

14.15 Effective MDT - The lead cancer physicians perspectiveG. Poston (Liverpool, UK)

15.00 Coffee break

15.15 Effective communication in the MDTC. Byrne (Liverpool, UK)

15.45 “The good, the bad and the ugly” - interactive critique ofthe MDT process J. Goulding (Liverpool, UK)

16.30 Visit to the MDT room and meet the MDT coordinators

17.00 End of the first day

Thursday, 23 July 2015

08.15 Join Multidisciplinary meeting for advanced colorectalcancer liver metastases diagnosis and treatmentHeld by local doctors

10.15 Coffee break

Multidisciplinary Team Seminar

10.30 Centralisation of liver surgery and impact of MDTworkingG. Poston (Liverpool, UK)

10.50 Defining resectability of CRC liver metastasesH. Malik (Liverpool, UK)

11.10 Imaging CRC liver mets (CT, MRI, PET) H. Wieshmann (Liverpool, UK)

11.30 Chemo and biological therapyC. Ton (Liverpool, UK)

11.50 Other novel treatment strategies in treating colorectalliver metastases Ablation and TACE G. Poston (Liverpool, UK)

12.15 Working lunch

13.30 The Patient’s perspectiveC. Byrne (Liverpool, UK)

Journal Club Session

13.50 Journal Club Part I Two recent and relevant papers will be presented anddiscussed in detail Held by local doctors

14.30 Coffee break

15.10 Journal Club Part II

16.00 End of the second day

8

Friday, 24 July 2015

Case study session

08.30 Case study sessionCase studies on participants' experience of MDT will bepresented and discussedHeld by local doctors

11.00 Coffee break

11.15 Case study session

12.30 End of the live educational preceptorship course

9

10

Disclosure of facultyrelationships

EXCEMED adheres to guidelines of the European AccreditationCouncil for Continuing Medical Education (EACCME®) and all otherprofessional organizations, as applicable, which state thatprogrammes awarding continuing education credits must bebalanced, independent, objective, and scientifically rigorous.Investigative and other uses for pharmaceutical agents, medicaldevices, and other products (other than those uses indicated inapproved product labeling/package insert for the product) may bepresented in the programme (which may reflect clinical experience,the professional literature or other clinical sources known to thepresenter). We ask all presenters to provide participants withinformation about relationships with pharmaceutical or medicalequipment companies that may have relevance to their lectures. Thispolicy is not intended to exclude faculty who have relationships withsuch companies; it is only intended to inform participants of anypotential conflicts so that participants may form their ownjudgements, based on full disclosure of the facts. Further, all opinionsand recommendations presented during the programme and allprogramme-related materials neither imply an endorsement nor arecommendation on the part of EXCEMED. All presentationsrepresent solely the independent views of the presenters/authors.

The following faculty provided information regarding significantcommercial relationships and/or discussions of investigational ornon-EMEA/FDA approved (off-label) uses of drugs:

Clare Byrne Declared no potential conflict of interest.

Hassan Malik Declared receipt of honoraria or consultationfees from Terumo.

Graeme Poston Declared receipt of honoraria or consultationfees from Merck Serono. Declared hisparticipation in a company sponsored speaker’sbureau: Merck Serono.

Hulya Wieshmann Declared no potential conflict of interest.

The following faculty have provided no information regardingsignificant relationship with commercial supporters and/ordiscussion of investigational or non-EMEA/FDA approved (off-label)uses of drugs as of 09 July 2015:Jeff GouldingChan Ton

11

Take a look at the oncology sectionof the EXCEMED website

EXCEMED has made a strong commitment to medical education inoncology and is developing live events such as workshops, expertmeetings and preceptorships, online activities, and otherprogrammes that will focus on key issues in oncology and themultidisciplinary approaches to patient management.

Visit the oncology section:

www.oncology.excemed.organd register to access free e-learning activities and receive updateson new events and resources.

16 t t ONCOLOGY FALL-WINTER 2014

www.excemed.orgIt’s active in here

IMPROVING THE PATIENT’S LIFE THROUGH

MEDICAL EDUCATION

EXCEMED at your fingertips> Six specialty micro sites, including oncology

> Accessible and accredited e-learning packages

> A world-class repository of CME knowledge and learning materials

> Monthly updates about our events and resources in oncology

> Register with us online and access it all – free

Better outcomes for patients start here. With over 40 years of experience, EXCEMED has been delivering continuing medical education (CME) longer than any other provider.

12

All EXCEMED programmes are organised solely to promote the exchange anddissemination of scientific and medical information. No forms of promotionalactivities are permitted. This programme is made possible thanks to an educationalgrant received from Merck Serono.

EXCEMED - Excellence in Medical EducationHeadquarters14, Rue du Rhône - 1204 Geneva, SwitzerlandRepresentative OfficeSalita di San Nicola da Tolentino 1/b - 00187 Rome, ItalyT +39 06 420413 1 - F +39 06 420413 677

Copyright © EXCEMED, 2015. All rights reserved.

Improving the patient's life through medical educationwww.excemed.org